Gerald E. Quirk's most recent trade in Syros Pharmaceuticals Inc. was a trade of 46,657 Common Stock done at an average price of $0.2 . Disclosure was reported to the exchange on Nov. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Syros Pharmaceuticals Inc. | Gerald E. Quirk | Chief Legal & Compliance Offic | 19 Nov 2024 | 46,657 | 0 (0%) | 0% | 0.2 | 10,321 | Common Stock | |
| Syros Pharmaceuticals Inc. | Gerald E. Quirk | Chief Legal & Compliance Offic | 30 Sep 2024 | 10,000 | 49,757 (0%) | 0% | - | Common Stock | ||
| Syros Pharmaceuticals Inc. | Gerald E. Quirk | Chief Legal & Compliance Offic | 30 Sep 2024 | 10,000 | 20,000 | - | - | Restricted Stock Units | ||
| Syros Pharmaceuticals Inc. | Gerald E. Quirk | Chief Legal & Compliance Offic | 30 Sep 2024 | 3,100 | 46,657 (0%) | 0% | 2.1 | 6,510 | Common Stock | |
| Syros Pharmaceuticals Inc. | Gerald E. Quirk | Chief Legal & Compliance Offic | 27 Mar 2024 | 22,500 | 46,803 (0%) | 0% | - | Common Stock | ||
| Syros Pharmaceuticals Inc. | Gerald E. Quirk | Chief Legal & Compliance Offic | 27 Mar 2024 | 22,500 | 0 | - | - | Restricted Stock Units | ||
| Syros Pharmaceuticals Inc. | Gerald E. Quirk | Chief Legal & Compliance Offic | 27 Mar 2024 | 7,046 | 39,757 (0%) | 0% | 5.6 | 39,387 | Common Stock | |
| Syros Pharmaceuticals Inc. | Gerald E. Quirk | Chief Legal Officer | 11 Oct 2022 | 45,000 | 45,000 | - | - | Restricted Stock Units | ||
| Syros Pharmaceuticals Inc. | Gerald E. Quirk | Chief Legal & Admin. Officer | 17 Feb 2021 | 94,000 | 94,000 | - | - | Stock Option (right to buy) |